Pharmaids Pharma — 360° view

Pharmaids Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹4.34 crore and a net loss of ₹1.81 crore for the September 2026 quarter.

Pharmaids Pharma (BSE: PHARMAID) closed at ₹21.26 on 20 Nov 2026, down 54.4% over the past year. Its market capitalisation is ₹75 crore.

Share price
₹21.26 (20 Nov 2026)
Market cap
₹75 Cr (20 Nov 2026)
Revenue
₹4 Cr (September 2026 quarter)
Net profit
₹-2 Cr (September 2026 quarter)
ROCE
-18.5% (FY26)
ROE
-26.5% (FY26)
Book value
₹13.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹53.90 / ₹19.90 (20 Nov 2026)
1-year return
-54.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: PHARMAID

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.